Elsevier

European Journal of Radiology

Volume 36, Issue 3, 1 December 2000, Pages 123-125
European Journal of Radiology

Case report
Tophaceous gout of the lumbar spine in a renal transplant patient: a case report and literature review

https://doi.org/10.1016/S0720-048X(00)00214-XGet rights and content

Abstract

Tophaceous gout of the spine is rare. We report the case of a 27-year-old male, renal transplant recipient, who presented with an acute onset of lower back pain. Radiological, biochemical and histo-pathological findings confirmed a diagnosis of tophaceous gout of the lumbar spine. We present the case history with the radiological findings and discuss the literature.

Introduction

Gout is a pathological condition resulting from monosodium urate or uric acid crystal deposition. It is predominantly idiopathic but can also be associated with other disorders such as chronic renal failure, myeloproliferative disease and drug therapy. Patients with inadequately treated acute gout may develop chronic tophaceous gout with nodular deposition of calcium urate in synovium, soft tissue and subchondral bone [1].

Tophaceous gout of the spine is rare. We report the first described case of a renal transplant recipient developing tophaceous gout of the lumbar spine and discuss the literature.

Section snippets

Case report

A 27-year-old male patient presented to the emergency room with a 24-hr history of right sided lower back pain. He had a background history of IgA nephropathy and hypertension and had been dialysis dependent until he received a cadaveric renal transplant in 1990. The transplant was functioning poorly with biopsy evidence of chronic rejection. He was maintained on dual anti-rejection therapy of cyclosporin A and oral corticosteroids. The patient had a documented history of non-tophaceous gout

Discussion

Renal transplant recipients are at an increased risk of developing gout [1]. Additional risk factors for the development of gout in this patient include a positive family history, chronic renal failure and cyclosporin A therapy. West et al. showed an 11.8% incidence of gout in 211 post-renal transplant patients receiving corticosteroids and Cyclosporin A [2].

Urate deposition in soft tissues is a well documented feature of gout, particularly in para-articular regions and in articular cartilage

Conclusion

Although involvement of the lumbar spine in gout is rare the diagnosis should be considered in high risk patients such as renal transplant recipients in whom there is an appropriate clinical history of backpain or related symptomatology. We describe the first reported case of tophaceous gout of the spine in a renal transplant recipient.

References (8)

There are more references available in the full text version of this article.

Cited by (30)

  • Gout in the spine

    2013, Revista Brasileira de Reumatologia
  • The Broad Spectrum of Urate Crystal Deposition: Unusual Presentations of Gouty Tophi

    2012, Seminars in Arthritis and Rheumatism
    Citation Excerpt :

    In fact, visible tophi have been seen in transplant patients before any other gouty symptoms have been reported. Although typical sites of gout are often seen in transplant recipients, more unusual sites such as the finger pads, within the patella, at entheses, at the costochondral junction, sacroiliac joints, and spine have all been reported (91-97). Anti-inflammatory and immunosuppressant medications taken to prevent transplant rejection, such as corticosteroids, can mask acute gouty symptoms and these patients can present with tophi as their initial manifestation of gout.

View all citing articles on Scopus
View full text